PELONews

New Product | Mag-Net HP™ Kit: Unleashing the Hidden 98% of the Plasma Proteome

In plasma proteomics, the proteins that matter most are often the hardest to see. With concentrations spanning >10 orders of magnitude, abundant carriers such as albumin routinely drown out low-abundance biomarkers linked to neuro­degeneration, cancer, and metabolic disease.

Advancing Blood-Brain Barrier (BBB) Research: Tools and Insights from PELOBiotech

PELOBiotech offers a comprehensive range of solutions for BBB research, including high-quality primary cells, growth media, and advanced platforms like midifluidic systems and 3D hydrogels.

PELOPaper: Blood-Brain Barrier Disruption in Autoimmune Encephalitis

A recent dissertation from Charité Universitätsmedizin Berlin by Lucie Yuanting Li explores the role of autoantibodies in autoimmune encephalitis, provides insights into mechanisms that disrupt the blood-brain barrier (BBB).

Meet us at...IGLD Symposium 2025 In Frankfurt

PELOBiotech is attending, IGLD symposium from 07 - 09 March 2025 , in Frankfurt. Join us and meet our CEO Dr. Peter Frost, our Marketing head Christiane B chsel and Sales Representative Magdalena Meier at the booth. Also you can schedule face-to-face interaction with our CEO Dr. Peter Frost and team.

Meet us at... Elrig Forum 2025 in Darmstadt

PELOBiotech is attending The ELRIG Forum on March 13, 2025 at the Science and Congress center "darmstadtium" in Darmstadt. Schedule your on-site meeting with our CEO Dr. Peter Frost , at our booth.

PELOPaper: Insights into Infant Formula and Immune Responses

A recent study published in the European Journal of Nutrition by Hedegger, Hommel, Schaubeck et al. explores the impact of different infant formulas on intestinal immune responses.

PELOPaper: Advanced Skin Research with a Psoriasis Skin Equivalent Model

A recent study introduces a bilayered skin equivalent that closely mimics psoriasis. This innovative model bridges a critical gap in preclinical studies, offering unparalleled insights into disease mechanisms and potential therapeutic interventions.

PELOPaper: Insights into Liver Endothelial Cell Function in Cirrhosis with PELOBiotech Products

A study published in Cellular and Molecular Gastroenterology and Hepatology highlights advances in understanding liver sinusoidal endothelial cells (LSECs) in cirrhosis, thanks to single-cell transcriptomics.

PELOPaper: Cellovations Lung Fibroblasts to Create 3D Vasculature-on-Chip Models

A recent study published in Advanced Materials Technologies highlights Cellovations products in advancing tissue engineering and microfluidic models.

2024 Trade Show Season Concludes with Success at MuSkITYR Symposium

We are pleased to announce the successful conclusion of our 2024 trade show engagements, culminating at the MuSkITYR Symposium in Vienna. Our CEO and CSO, Dr. Lothar Steeb, had an engaging and productive experience, and we look forward to connecting with everyone again next year.

iPSC-Derived Cardiomyocytes: Advancing Cardiac Research & Drug Discovery

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are transforming cardiac research and drug discovery. Pioneered by Takahashi and Yamanaka, these cells are crucial for disease modeling and drug safety. 

Extracellular Vesicles (EVs) Explained: The Ultimate Guide to Exosome Research in 2024

Unlock the secrets of extracellular vesicles (EVs) and explore their groundbreaking role in cell communication, disease pathways, and targeted therapies.